Moderna’s Booster Shot Targeting Omicron And Original Strain Could Be Available Late Summer After Promising Trials Moderna chief executive Stéphane Bancel said early data suggests the bivalent shot could provide more long-lasting protection against variants of concern than the company’s original formula alone.